ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,370Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 37

$768K Total Retail Price of All Prescriptions

Rank: 1 out of 37

675 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 675 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 675 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 14,887 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
FUROSEMIDE 770 680 1 5
SIMVASTATIN 755 694 2 4
OMEPRAZOLE 718 621 3 1
LEVOTHYROXINE SODIUM 650 573 4 6
AMLODIPINE BESYLATE 496 474 5 11
METOPROLOL SUCCINATE 490 446 6 23
POTASSIUM CHLORIDE 478 407 7 15
HYDROCODONE-ACETAMINOPHEN 445 351 S3 8 2
METOPROLOL TARTRATE 419 388 9 12
LISINOPRIL 411 376 10 9
HYDROCHLOROTHIAZIDE 371 329 11 16
WARFARIN SODIUM 364 343 12 13
METFORMIN HCL 358 297 13 19
TAMSULOSIN HCL 299 290 14 8
TRAMADOL HCL 274 220 15 10
ATORVASTATIN CALCIUM 235 229 16 42
GABAPENTIN 206 151 17 3
PRAVASTATIN SODIUM 204 166 18 51
GLIMEPIRIDE 195 184 19 52
LOSARTAN POTASSIUM 190 175 20 29
RANITIDINE HCL 189 141 21 31
CITALOPRAM HBR 174 147 22 24
DIGOXIN 165 160 23 64
ALLOPURINOL 161 156 24 21
MIRTAZAPINE 151 116 25 79
CRESTOR 146 127 26 63
POLYETHYLENE GLYCOL 3350 144 99 27 34
ATENOLOL 138 122 28 25
ZETIA 115 87 29 92
PLAVIX 108 101 30 68
MELOXICAM 101 79 31 32
NAMENDA 99 99 32 33
DIOVAN 98 98 33 97
ENALAPRIL MALEATE 97 86 34 98
NEXIUM 95 73 35 62
RAMIPRIL 93 60 36 104
FAMOTIDINE 92 63 37 105
ALENDRONATE SODIUM 92 92 37 43
SERTRALINE HCL 90 70 39 56
PROPRANOLOL HCL 88 63 40 48
ZOLPIDEM TARTRATE 88 81 40 74
DONEPEZIL HCL 87 87 42 22
PROAIR HFA 86 75 43 86
LOVASTATIN 82 82 44 44
FINASTERIDE 75 75 45 37
OXYBUTYNIN CHLORIDE 74 67 46 47
CLONIDINE HCL 72 64 47 88
DIOVAN HCT 71 61 48 114
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 60 48 41
AZITHROMYCIN 71 63 48 114
PREDNISONE 70 69 51 7
CYCLOBENZAPRINE HCL 70 41 R 51 71
IBUPROFEN 66 55 53 117
CLOPIDOGREL 66 56 53 39
DOXAZOSIN MESYLATE 66 66 53 46
ISOSORBIDE MONONITRATE ER 65 55 56 86
TERAZOSIN HCL 63 63 57 78
LANTUS 62 49 58 121
ADVAIR DISKUS 61 47 59 91
CEPHALEXIN 61 51 59 35
NOVOLOG FLEXPEN 61 38 59 122
AMITRIPTYLINE HCL 61 51 R 59 69
PAROXETINE HCL 60 58 63 90
LYRICA 59 51 64 45
TRIAMTERENE-HCTZ 59 47 64 126
LOSARTAN-HYDROCHLOROTHIAZIDE 58 54 66 131
RISPERIDONE 57 55 67 134
CARBIDOPA-LEVODOPA 56 51 68 14
ZOSTAVAX 56 48 68 137
QUINAPRIL HCL 56 56 68 137
SPIRIVA 55 55 71 93
PANTOPRAZOLE SODIUM 55 47 71 26
FLUTICASONE PROPIONATE 55 41 71 65
METOLAZONE 54 36 74 140
TRICOR 54 36 74 140
CARVEDILOL 53 43 76 60
LANTUS SOLOSTAR 53 53 76 144
LIPITOR 52 42 78 145
AMLODIPINE BESYLATE-BENAZEPRIL 50 41 79 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.